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Introduction This study investigates the optimal target delineation protocol strati-
fied by treatment planning technique in patients undergoing whole breast radiother-
apy after breast conservation surgery.
Materials and Methods Target delineation using Tangent (RTOG 0413 Whole Breast 
Irradiation Protocol), European SocieTy for Radiotherapy and Oncology (ESTRO), and 
Radiation Therapy & Oncology Group (RTOG) guidelines was performed on 10 randomly 
selected treatment planning computed tomography datasets of patients with left-
sided breast cancer. An objective plan quality metric (PQM) scoring schema was 
defined and communicated to the medical physicist prior to commencement of treat-
ment planning. Treatment planning was performed using field-in-field (FiF) intensity 
modulated radiotherapy technique (IMRT), inverse IMRT, and volumetric modulated 
arc therapy (VMAT), for each type of target. Two-way repeated measures, analysis of 
variance was utilized to compare the total PQM scores and dosimetric variables, strat-
ified by treatment planning method.
Results Total PQM score of plans for FiF, IMRT, and VMAT revealed that Tangent and 
ESTRO delineations were equivalent regardless of planning technique (Tangent vs. 
ESTRO for FiF, p = 0.099; Tangent vs. ESTRO for IMRT, p = 0.029; Tangent vs. ESTRO for 
VMAT, p = 0.438). Both delineation protocols were significantly superior to RTOG for all 
treatment planning techniques.
Conclusion For all treatment planning techniques, ESTRO and Tangent delineation 
were equivalent and both achieved significantly higher scores than RTOG delineation.
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Introduction
Treatment planning for breast irradiation has evolved from 
conventional fields based on marks placed around the breast 
to modern three-dimensional computed tomography (3D 
CT)-based planning. Recognition of the late effects associ-
ated with breast irradiation is manifested primarily as an 
increased risk of long-term cardiac mortality, specifically in 
left-sided breast cancer.1,2 Technologically advanced radio-
therapy delivery techniques have allowed a reduction in 
whole heart mean dose, which has emerged as the strongest 
predictor of radiation-induced cardiac mortality.3-5 Paralleling 
technological advances, guidelines have been formulated for 
the delineation of the whole breast target volume, though 
issues of interobserver variation persist.6-8 These parallel 
developments in target delineation and treatment delivery 
techniques have aided the evolution from conventional to 3D 
CT-based planning.
While the dosimetric performance of modern radiother-
apy delivery techniques has been compared, meaningful 
interpretation is hampered by, but not limited to issues of 
type of target delineation performed, treatment planning 
proficiency and the large number of dosimetric parame-
ters evaluated. As radiotherapy techniques and delineation 
guidelines continue to evolve, disentangling the confounding 
effects of both on each other may be difficult and is not cur-
rently addressed in the literature.
The purpose of this research was to determine the most 
optimal target delineation protocol for a given type of treat-
ment planning technique, using an objective plan quality 
assessment tool.
Materials and Methods
We have previously reported the methodology for this 
analysis (►Fig. 1).9 In brief, we selected 10 left-sided breast 
cancer patients from our institutional database who had 
undergone breast conservation surgery and adjuvant radio-
therapy (46Gy in 23Fx with an electron boost of 12.5Gy in 
5Fx to lumpectomy cavity). All patients had undergone a 
free-breathing CT scan on Siemens Somatom Sensation Open 
with a slice thickness of 2 mm. Their DICOM CT datasets was 
retrieved, and target delineation was performed based on 
the RTOG 0413 (Tangent) Whole Breast Irradiation protocol, 
the RTOG (Radiation Therapy Oncology Group) consensus 
and ESTRO (European SocieTy of Radiation Therapy) con-
sensus guidelines.6,7,10 Organs-at-risk (OAR), the left anterior 
descending (LAD) artery, and left ventricle (LV) were delin-
eated as described in the RTOG 1005 protocol (NCT01349322) 
and a cardiac atlas, respectively.11
Subsequently, treatment planning was performed using 
field-in-field (FiF) intensity modulated radiotherapy tech-
nique (IMRT), inverse optimized IMRT, and volumetric mod-
ulated arc therapy (VMAT).12-19 To minimize interobserver 
variation, one radiation oncologist performed delineation 
of all structures on a single treatment planning system 
(Varian Eclipse v13.5, Varian Medical Systems) and a single 
medical physicist performed treatment planning on a single 
TPS (Varian Eclipse v13.5; AAA algorithm, Varian Medical 
Systems, Palo Alto, CA, United States) and delivery platform 
(Varian TrueBeam v2.5; Millennium 120 MLC, Varian Medical 
Systems).
Plan quality assessment was performed using an objec-
tive plan quality metric (PQM) scale.9,20 Dosimetric data from 
each plan for each structure was extracted from exported 
DVH files using DVHmetrics v0.3.5 (www.rdocumentation.
org/packages/DVHmetrics), per level 2 reporting recommen-
dations by the ICRU Report 83.21
Statistical comparison was performed using a two-way 
repeated measure, analysis of variance (ANOVA), after cor-
recting for any possible interaction between target delinea-
tion protocol and planning technique in each ANOVA model.22 
A Bonferroni correction was applied, and the significance 
level was set at <0.005 (0.05/9).23 All analyses were per-
formed in Stata 14.2 SE (Statacorp Inc, College Station, TX, 
United States) statistical software.
Results
Ninety plans were selected from a pool of 450 generated 
plans on the basis of PQM score and minimum acceptance 
criteria.9 Descriptive data associated with PQM and dosim-
etric comparisons is provided in ►Supplementary Material 
(available in the online version).
PQM-Based Comparison of Delineation Guidelines 
For plans based on FiF IMRT, the combined PQM scores for 
Tangent delineation were equivalent to ESTRO delineation 
(Tangent vs. ESTRO, p = 0.099) and both were significantly 
superior to RTOG delineation (Tangent vs. RTOG, p < 0.001; 
ESTRO vs. RTOG, p < 0.001) (►Fig.  2). The subscore anal-
ysis revealed that the planning target volume (PTV) score 
for ESTRO delineation was higher than both RTOG and 
Tangent delineations (ESTRO vs. RTOG, p < 0.001; ESTRO vs. 
Tangent, p = 0.001), and that Tangent delineation was supe-
rior to RTOG delineation (Tangent vs. RTOG, p = 0.001). The 
comparison of subscores for left lung, heart, and right breast 
revealed that ESTRO and Tangent delineations were equiva-
lent and that both were superior to RTOG delineation.
For plans based on inverse optimized IMRT, the combined 
PQM scores for Tangent delineation were equivalent to ESTRO 
delineation (Tangent vs. ESTRO, p = 0.029) and both were sig-
nificantly superior to RTOG delineation (Tangent vs. RTOG, 
p < 0.001; ESTRO vs. RTOG, p < 0.001) (►Fig. 3). The subscore 
analysis for PTV score revealed that all delineation protocols 
were equivalent. The comparison of subscores for heart and 
right breast revealed that Tangent and ESTRO delineations 
were equivalent and both were superior to RTOG delineation. 
When comparing subscores for left lung, ESTRO delineation 
was superior to both RTOG and Tangent delineation protocols 
(ESTRO vs. RTOG, p < 0.001; ESTRO vs. Tangent, p = 0.003), 
and Tangent delineation was superior to RTOG delineation 
(Tangent vs. RTOG, p = 0.001).
For plans based on VMAT planning technique (►Fig. 4), the 
combined PQM scores for Tangent delineation were equiva-
lent to ESTRO delineation (Tangent vs. ESTRO, p = 0.438) and 
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each plan for each structure was extracted from exported 
DVH files using DVHmetrics v0.3.5 (www.rdocumentation.
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revealed that ESTRO and Tangent delineations were equiva-
lent and that both were superior to RTOG delineation.
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were equivalent and both were superior to RTOG delineation. 
When comparing subscores for left lung, ESTRO delineation 
was superior to both RTOG and Tangent delineation protocols 
(ESTRO vs. RTOG, p < 0.001; ESTRO vs. Tangent, p = 0.003), 
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lent to ESTRO delineation (Tangent vs. ESTRO, p = 0.438) and 
Fig. 1 Study design.9 ESTRO, European SocieTy for Radiotherapy and Oncology; IMRT, intensity modulated radiotherapy technique; PQM, plan 
quality metric; RTOG, Radiation Therapy & Oncology Group; VMAT, volumetric modulated arc therapy.
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both were significantly superior to RTOG delineation (Tangent 
vs. RTOG, p = 0.001; ESTRO vs. RTOG, p < 0.001) (►Fig. 4). The 
subscore analysis for PTV score and right breast revealed that 
all delineation protocols were equivalent. When comparing 
Fig. 2 Box and whisker plots for PQM score comparison of delineation protocols based on field-in-field planning technique. ESTRO, European 
SocieTy for Radiotherapy and Oncology; FiF, field-in-field IMRT; IMRT, intensity modulated radiotherapy technique; PQM, plan quality metric; 
RTOG, Radiation Therapy & Oncology Group; TANG, RTOG 0413 (Tangent) Protocol; VMAT, volumetric modulated arc therapy.
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Fig. 3 Box and whisker plots for PQM score comparison of delineation protocols based on inverse optimized intensity modulated radiotherapy tech-
nique. ESTRO, European SocieTy for Radiotherapy and Oncology; FiF, field-in-field IMRT; IMRT, intensity modulated radiotherapy technique; PQM, 
plan quality metric; RTOG, Radiation Therapy & Oncology Group; TANG, RTOG 0413 (Tangent) Protocol; VMAT, volumetric modulated arc therapy.
subscores for the heart, ESTRO and Tangent delineation pro-
tocols were equivalent (ESTRO vs. Tangent, p = 0.353) and 
RTOG was inferior to ESTRO (RTOG vs. ESTRO, p = 0.001) but 
equivalent to Tangent delineation protocol (RTOG vs. Tangent, 
18
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p = 0.009). For the left lung, ESTRO was equivalent to Tangent 
delineation protocol (ESTRO vs. Tangent, p = 0.907) and both 
were superior to RTOG delineation protocol (ESTRO vs. RTOG, 
p < 0.001; ESTRO vs. Tangent, p < 0.001).
Fig. 4 Box and whisker plots for PQM score comparison of delineation protocols based on VMAT technique. ESTRO, European SocieTy for 
Radiotherapy and Oncology; FiF, field-in-field IMRT; IMRT, intensity modulated radiotherapy technique; PQM, plan quality metric; RTOG, 
Radiation Therapy & Oncology Group; TANG, RTOG 0413 (Tangent) Protocol; VMAT, volumetric modulated arc therapy.
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Dosimetric Comparison of Delineation Guidelines
►Fig.  5 provides a summarized visual representation of 
the results of dosimetric comparison for all structures and 
dosimetric parameters analyzed (full descriptive data with 
associated p-values are provided in Supplemental Material, 
available in the online version). The data visualization 
technique chosen for comprehensively depicting results 
of all dosimetric comparisons is a modified version of the 
sunburst chart.24 Each analyzed structure and its associ-
ated dosimetric parameters form the origin of hierarchy, 
and three concentric circles represent the rank order, with 
the innermost circle being most inferior. Each dosimet-
ric parameter has three radial arms representing planning 
technique, upon which the comparators (target delineation 
guidelines) are ranked. This method of qualitative data visu-
alization was chosen because the values being compared 
were not on a uniform scale.
1. PTV parameters (►Fig. 5A)
Across all planning techniques, RTOG delineation proto-
col was either dosimetrically inferior to ESTRO delineation 
protocol (12/24 comparisons) or the overall comparison 
between all delineation protocols was not statistically sig-
nificant (11/24 comparisons). The comparisons for tangent 
delineation protocol were more heterogeneous. Tangent 
delineation was in nearly equal measures dosimetrically 
superior to (7/24 comparisons) or equivalent to RTOG delin-
eation (6/24 comparisons).
2. Heart, LAD artery, and LV parameters (►Fig. 5B–D)
For the whole heart contour, across almost all dosimetric 
parameters and planning techniques, RTOG delineation was 
dosimetrically inferior to both ESTRO and Tangent delineation 
(23/30 comparisons), except D2% for IMRT planning where it 
was dosimetrically equivalent to Tangent delineation. Except 
for the comparisons where there was no statistically signifi-
cant difference amongst all delineations (6/30 comparisons), 
ESTRO delineation was dosimetrically equivalent to Tangent 
delineation across all planning techniques and dosimetric 
parameters (23/30 comparisons).
The dosimetric comparisons for LAD revealed that RTOG 
delineation was dosimetrically inferior to ESTRO delineation 
(12/21 comparisons) and Tangent delineation was dosimet-
rically equivalent to ESTRO delineation (9/21 comparisons). 
Overall in 9/21 comparisons, there was no statistically signif-
icant difference among all delineations.
Similarly, almost all dosimetric comparisons for the LV 
demonstrated that RTOG delineation was dosimetrically 
inferior to ESTRO delineation (16/21 comparisons), irrespec-
tive of planning technique. Tangent delineation was dosimet-
rically equivalent to ESTRO delineation for most comparisons 
(15/21 comparisons), except D2% with IMRT technique where 
it was dosimetrically inferior.
3.  Left lung (►Fig. 5E)
For the left lung, across all planning techniques and 
almost all dosimetric parameters, RTOG delineation pro-
tocol was dosimetrically inferior to ESTRO delineation pro-
tocol (23/24 comparisons). Tangent delineation protocol 
was dosimetrically equivalent to ESTRO delineation pro-
tocol for almost all comparisons (20/24 comparisons) and 
consequently dosimetrically superior to RTOG delineation 
for almost all comparisons (22/24 comparisons).
4.  Right breast (►Fig. 5F)
Except for two comparisons (V2 and V3 for VMAT planning) 
where ESTRO delineation was dosimetrically equivalent to 
RTOG delineation, across all planning techniques and almost 
all comparisons for the right breast, either RTOG delineation 
was dosimetrically inferior to both ESTRO and Tangent delin-
eations (16/24 comparisons), or there was no significant dif-
ference between delineation protocols (6/24 comparisons).
Discussion
We believe that this study is the first to analyze the perfor-
mance of contouring protocols when viewed from the per-
spective of the medical physicist (which is the most optimal 
target delineation technique for a particular planning tech-
nique?). Our results suggest that irrespective of the planning 
technique employed, total PQM scores for ESTRO and Tangent 
delineation were equivalent and both achieved significantly 
higher scores than RTOG delineation.
Our results on the performance of delineation guide-
lines can be explained by the shared similarities of Tangent 
and ESTRO delineation guidelines. The principle behind the 
ESTRO guideline is that target delineation should not result 
in volumes larger than “conventional” simulator-based RT 
volumes.7 A notable difference of the ESTRO guideline is to 
restrict the dorsal border at the pectoralis major muscle and 
gradually move ventrally near the caudal edge to exclude 
subcutaneous abdominal fat. However, despite this modifi-
cation in the ESTRO guidelines, the heart subscores between 
Tangent and ESTRO delineations were not significantly differ-
ent (despite the Tangent delineation including the chest wall). 
The known issue of variation in the medial–lateral direction 
influencing OAR dose can explain the performance of the 
RTOG delineation, though delineation was in strict adher-
ence to the published guideline.8 Furthermore, our study did 
not permit any contour modification after the plans were 
obtained, in contrast to common clinical practice.8
Our analysis can be criticized as being antithetical to 
modern radiotherapy practice with limited applicability, as 
planning technique is determined by target delineation and 
not vice-versa. We want to emphasize that our objective was 
purely exploratory and the intent of which was to empirically 
compare delineation protocols, controlling for as many vari-
ables as possible. Obviously, the gold standard for comparing 
delineation protocols would be clinical data on local fail-
ures. Data on regional nodal failures stratified by delineation 
protocols is now emerging, and while our analysis was not 
designed to assess the quality of regional nodal irradiation, 
this is an important avenue for research and our group will 
be addressing it in the near future.25
Our analysis shows that if a particular planning technique 
is preferred, some thought should be given to the delinea-
tion protocol best suited for it. At this time, in the absence 
of a local control analysis, it is impossible to decide whether 
ESTRO or RTOG delineation guidelines should be followed, 
and until such a report appears, radiation oncologists can 
20
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Fig. 5 Modified sunburst charts of dosimetric comparisons, depicting the ordinal performance of delineation guidelines stratified by planning 
technique (please refer ►Supplementary Material, available in the online version, for descriptive data). (A) Planning target volume (PTV), 
(B) heart, (C) left anterior descending (LAD) artery, (D) left ventricle (LV), (E) left lung, and (F) right breast.
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choose either. The results of this analysis and a companion 
analysis9 support our conclusion that either FiF or IMRT 
when coupled with Tangent or ESTRO delineation protocol 
yields the most optimal combination of target coverage and 
OAR sparing. We therefore advise against the routine use of 
RTOG delineation or VMAT planning technique purely on 
plan quality and dosimetric grounds and await the results of 
clinical trials utilizing the RTOG delineation guidelines. Just 
as planning techniques are sympathetic to delineation pro-
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